We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+4.66%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$185M
AUM Growth
-$4.95M
Cap. Flow
-$7.94M
Cap. Flow %
-4.29%
Top 10 Hldgs %
49.31%
Holding
46
New
8
Increased
10
Reduced
9
Closed
15

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$7.74M
2
MDT icon
Medtronic
MDT
+$6.71M
3
BAX icon
Baxter International
BAX
+$5.72M
4
AZN icon
AstraZeneca
AZN
+$5.06M
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$4.47M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$5.24M
2
LLY icon
Eli Lilly
LLY
+$4.99M
3
ABBV icon
AbbVie
ABBV
+$4.44M
4
BMY icon
Bristol-Myers Squibb
BMY
+$3.96M
5
UNH icon
UnitedHealth
UNH
+$3.83M

Sector Composition

Rank Sector Weight
1 Healthcare 87.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
1
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$20.3M 10.96%
250,000
+50,000
+25% +$4.47M
BSX icon
2
Boston Scientific
BSX
$71.5B
$10.1M 5.45%
100,000
-10,000
-9% -$1.01M
THC icon
3
Tenet Healthcare
THC
$21.1B
$9.41M 5.09%
70,000
+15,000
+27% +$1.98M
HCA icon
4
HCA Healthcare
HCA
$89.5B
$8.64M 4.67%
25,000
+5,000
+25% +$1.61M
LLY icon
5
Eli Lilly
LLY
$1.06T
$7.43M 4.02%
9,000
-6,000
-40% -$4.99M
MCK icon
6
McKesson
MCK
$101B
$7.4M 4%
11,000
-4,000
-27% -$2.47M
DHR icon
7
Danaher
DHR
$144B
$7.17M 3.88%
35,000
+10,000
+40% +$2.18M
COR icon
8
Cencora
COR
$61.2B
$6.95M 3.76%
25,000
– –
ISRG icon
9
Intuitive Surgical
ISRG
$134B
$6.93M 3.75%
+14,000
New +$7.74M
CAH icon
10
Cardinal Health
CAH
$55.4B
$6.89M 3.72%
50,000
– –
MDT icon
11
Medtronic
MDT
$112B
$6.74M 3.64%
+75,000
New +$6.71M
SYK icon
12
Stryker
SYK
$130B
$6.51M 3.52%
17,500
-2,500
-13% -$951K
WAT icon
13
Waters Corp
WAT
$39.9B
$6.27M 3.39%
17,000
+3,000
+21% +$1.16M
UHS icon
14
Universal Health Services
UHS
$10.5B
$6.11M 3.3%
32,500
-5,000
-13% -$912K
HUM icon
15
Humana
HUM
$46.2B
$6.09M 3.29%
23,000
+3,000
+15% +$811K
BAX icon
16
Baxter International
BAX
$14.2B
$5.99M 3.24%
+175,000
New +$5.72M
ABT icon
17
Abbott
ABT
$187B
$5.97M 3.23%
45,000
-5,000
-10% -$636K
A icon
18
Agilent Technologies
A
$41.2B
$5.85M 3.16%
50,000
+15,000
+43% +$2.02M
EHC icon
19
Encompass Health
EHC
$12.4B
$5.23M 2.83%
51,600
+6,600
+15% +$644K
AZN icon
20
AstraZeneca
AZN
$250B
$5.14M 2.78%
+35,000
New +$5.06M
NVO
21
Novo Nordisk
NVO
$209B
$4.86M 2.63%
70,000
– –
GILD icon
22
Gilead Sciences
GILD
$165B
$4.48M 2.42%
+40,000
New +$4.13M
CI icon
23
Cigna
CI
$74.6B
$4.11M 2.22%
12,500
+500
+4% +$151K
SNN icon
24
Smith & Nephew
SNN
$12.6B
$3.4M 1.84%
120,000
-5,000
-4% -$134K
SEM
25
DELISTED
Select Medical
SEM
$3.34M 1.81%
200,000
+50,000
+33% +$920K
1
2

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
A
AFBI Miami Beach, Florida $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return

Sivik Global Healthcare's Q1 2025 Portfolio in Review

As of Q1 2025, Sivik Global Healthcare held 46 positions worth $185M, down 2.6% from $190M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Sivik Global Healthcare withdrew a net $7.94M in Q1 2025, closing 15 positions and reducing 9 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $5.24M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 86% a quarter earlier.

Against the trend, Sivik Global Healthcare opened a new position in Intuitive Surgical worth $6.93M.

  • Sivik Global Healthcare's largest Q1 2025 buy was Intuitive Surgical: 14,000 shares worth $6.93M.
  • Sivik Global Healthcare added most to State Street SPDR S&P Biotech ETF in Q1 2025, an estimated $4.47M increase.
  • Sivik Global Healthcare's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $4.99M.
  • Sivik Global Healthcare fully exited Vertex Pharmaceuticals in Q1 2025, selling an estimated $5.24M.
  • Sivik Global Healthcare's ten largest holdings make up 49% of its $185M portfolio in Q1 2025.
  • Sivik Global Healthcare opened 8 new positions and closed 15 in Q1 2025.
  • Sivik Global Healthcare's portfolio value fell 2.6% quarter-over-quarter to $185M.

Based on Sivik Global Healthcare's 13F filing for Q1 2025, filed 22 Apr 2025.